Scientists may finally know what causes Alzheimer’s
New Scientist: A team of international scientists led by Cortexyme, Inc., a privately held, the clinical-stage pharmaceutical company has recently discovered the role of a common bacterium, Porphyromonas gingivalis (Pg), in driving Alzheimer’s disease pathology. Through this study, they demonstrated the potential for small molecule inhibitors to block the pathogen. Stephen Dominy, M.D., Cortexyme co-founder,…